Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Income from Continuing Operations (2019 - 2025)

Biodesix (BDSX) has disclosed Income from Continuing Operations for 7 consecutive years, with 4026000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 52.08% year-over-year to 4026000.0, compared with a TTM value of 35589000.0 through Dec 2025, up 16.76%, and an annual FY2025 reading of 35589000.0, up 16.76% over the prior year.
  • Income from Continuing Operations was 4026000.0 for Q4 2025 at Biodesix, up from 9125000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 4026000.0 in Q4 2025 and bottomed at 18764000.0 in Q1 2023.
  • Average Income from Continuing Operations over 5 years is 11666500.0, with a median of 11509500.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations crashed 292.35% in 2021, then soared 52.08% in 2025.
  • Year by year, Income from Continuing Operations stood at 13175000.0 in 2021, then fell by 24.78% to 16440000.0 in 2022, then surged by 44.05% to 9199000.0 in 2023, then grew by 8.67% to 8401000.0 in 2024, then skyrocketed by 52.08% to 4026000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for BDSX at 4026000.0 in Q4 2025, 9125000.0 in Q3 2025, and 11617000.0 in Q2 2025.